Front Endocrinol 13(July):114 Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ (2017) Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis
Diet and lifestyle considerations specific to this combination Hashimoto's patients on GLP-1 medications need a more strategic approach to nutrition than the average GLP-1 user
Lee MMY, Kristensen SL, Gerstein HC, McMurray JJV, Sattar N (2022) Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial
Detoxification: Supports the body's natural detox processes, promoting clearer skin
How long does medicine stay in breast milk